RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India.

Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India.

Add to Collection
2022 May 17 Others A Ghosh, K Dutta, SP Bhatt, R Gupta… - The Journal of …, 2022 - academic.oup.com

Full Author : ['Ghosh, Amerta', 'Dutta, Koel', 'Bhatt, Surya Prakash', 'Gupta, Ritesh', 'Tyagi, Kanika', 'Ansari, Irshad Ahmad', 'Venugopal, Vasantha Kumar', 'Mahajan, Harsh', 'Pandey, Ravindra Mohan', 'Pandey, Shivam', 'Misra, Anoop']
Journal Title : The Journal of clinical endocrinology and metabolism
Chapter : Section3
Journal Year : 2022
Cited by : 10.0

CONTEXT: Excess hepatic and pancreatic fat may contribute to hyperglycemia. OBJECTIVE: The objective of this study was to examine the effect of dapagliflozin (an SGLT2 inhibitor) on anthropometric profile, liver, and pancreatic fat in patients with type 2..... Read More

Keywords : ["dapagliflozin improve body fat patterning", "pancreatic fat", "type diabetes", "north india", "patient", "hepatic"]
PubMed Link : https://academic.oup.com/jcem/article-abstract/107/6/e2267/6545841
Google Scholar Link : https://scholar.google.com/scholar?cites=3592681538097886950&as_sdt=2005&sciodt=0,5&hl=en&num=20